meds for buy
 
top2-3
Contact Us contactus Ελληνικά flag
top3-3
THE SOCIETY
NATIONAL CONGRESS
WORKING GROUPS SEMINARS
REGIONAL CONGRESSES OF THE HELLENIC CARDIOLOGICAL SOCIETY
SCIENTIFIC PROGRAMS
WORKING GROUPS-OLD STRUCTURE
WORKING GROUPS-NEW STRUCTURE
EDUCATION
HELLENIC JOURNAL OF CARDIOLOGY
HELLENIC JOURNAL OF CARDIOLOGY- New!
CALENDAR
LINKS
INTERNATIONAL JOURNALS
PATIENT NEWS
WEBINARS
GUIDELINES
YOUNG CARDIOLOGISTS
ACTIONS OF THE HELLENIC CARDIOLOGICAL SOCIETY
NEWS FROM ESC
STUDIES
REGISTRIES
PROTOCOLS
 
Clinical Issues
REVIEWS
Prevention
Imaging
Arterial Hypertention
Valvular Heart Disease
Thromboembolism Disease
Αrrhythmias
Coronary Artery Disease
Cardiomyopathies
Heart Failure
Echocardiography
more>>
INTERVIEWS
Atrial Fibrillation
Myocardial Infarction. How much are we at risk?
more>>
 
ESC Guidelines
COMPENDIUM of Abridged ESC Guidelines 2010
European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary
Prevention of Cardiovascular Disease
Hypertension
more>>
Special Links
 
Special Releases
NEW PUBLICATIONS
more>>
 
challenge
Herodotos
Scientific Highlights
Worsening migraines with hormone replacement linked to increased stroke risk in women
Postmenopausal women who experience worsening migraines while using hormone therapy had an increased risk for stroke compared with women who...
Pregnancy at older age may increase risk for future stroke
Women who become pregnant at age 40 years and older face a greater risk for stroke later in life compared with women who become pregnant...
FDA approves rosuvastatin for use in youth aged 8 to 17 with HeFH
AstraZeneca announced that the FDA has approved rosuvastatin to reduce total cholesterol, LDL and apolipoprotein B in pediatric patients aged...
Dabigatran approved for DVT, PE prophylaxis after hip replacement surgery
Boehringer Ingelheim announced that the FDA has approved a new indication for dabigatran to prevent deep vein thrombosis or pulmonary embolism...
Novel HF therapy associated with reduction in 30-day rehospitalizations
A novel HF therapy reduced 30-day readmissions after hospitalization for HF compared with enalapril, according to new data from the...
FDA approves app-based pacemaker monitoring system
Medtronic announced that it has received FDA approval for a mobile app-based remote monitoring system for patients with implantable pacemakers,...
Highlights from AHA 2015 Scientific Sessions
SPRINT: Aggressive BP target confers lower risk for death, CV events A systolic BP target of less than 120 mm Hg was associated with lower rates...
FDA Okays First Novel Oral Anticoagulant Reversal Agent
Idarucizumab reverses the blood-thinning effects of dabigatran The FDA has approved the first reversal agent for a novel oral anticoagulant...
New guideline focuses on management of adults with supraventricular tachycardia
The American College of Cardiology, American Heart Association and Heart Rhythm Society have released a guideline on best practices for...
Τhe Committee for Medicinal Products for Human Use (CHMP) of EMA adopted a positive opinion for the specific reversal agent for dabigatran
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of...
AF associated with elevated risk for dementia regardless of stroke
Adults with atrial fibrillation had a higher risk for dementia than those without atrial fibrillation, regardless of whether they had...
ESC Congress 2015
ODYSSEY trials demonstrate PCSK9 inhibitor efficacy, raise awareness of HeFH CoreValve ADVANCE: TAVI safe for patients at intermediate,...
FDA approves alirocumab, first injectable lipid-lowering
The Food and Drug Administration has approved the PCSK9 inhibitor alirocumab as a treatment for hypercholesterolemia, making this the first...
FDA approves new treatment for HF
The FDA has approved a first-in-class angiotensin receptor-neprilysin inhibitor for the reduction of CV death and HF-related hospitalization...
FDA strengthens warning of link between NSAIDs and MI, stroke
The FDA is strengthening a label warning of increased risk for MI or stroke associated with the use of nonsteroidal anti-inflammatory drugs,...
FDA warns of serious adverse events with LAA closure via suture delivery device
The FDA has issued a safety announcement warning of deaths and other serious adverse events associated with left atrial appendage closure via...
Idarucizumab: Clotting normalized in most patients with serious bleeding or needing surgery
Idarucizumab restored clotting in most patients on the new oral anticoagulant (NOAC) dabigatran (Pradaxa) who had serious bleeding or required...
FDA panel recommends approval of evolocumab
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted to recommend approval of evolocumab for reduction of LDL. The...
FDA advisory committee votes to recommend approval for alirocumab
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee today voted 13-3 that the benefits of LDL lowering via alirocumab, a human...
IMPROVE-IT published: Adding ezetimibe to simvastatin lowers LDL, improves CV outcomes
Confirming findings previously presented, adding ezetimibe to statin therapy lowered LDL levels and improved CV outcomes in patients with ACS,...
more>>
Case Reports
 
GIANT CARDIAC HYDATID CYST WITH RARE ADHESIONS We present a 29-year-old woman admitted... QUADRICUSPID PULMONARY VALVE IN AN ADULT PATIENT We describe a case of quadricuspid pulmonary...
 
more>>
Hot Articles
Ticagrelor shows better results than clopidogrel in patients with low risk ACS undergoing PCI In low-risk patients with ACS who undergo ad hoc PCI, a loading dose of ticagrelor was associated with greater effects on platelet inhibition and lower high on-treatment platelet reactivity...
Statin therapy reduces MACE, mortality in asymptomatic PAD Patients with a low ankle-brachial index, but without clinically recognized CVD, may experience lower major adverse CV events and mortality rates while on statin therapy. J Am Coll...
Rivaroxaban antidote met all endpoints in phase 3 ANNEXA-R study Andexanet alfa, a novel agent for reversal of Factor Xa-inhibitor anticoagulation, successfully reversed the effects of rivaroxaban in elderly individuals, according to data presented at the...
Beta-blockers may increase perioperative MACE, mortality risk in uncomplicated hypertension Perioperative treatment with a beta-blocker may be linked to elevated risk for major adverse CV events and all-cause mortality in patients with uncomplicated hypertension undergoing noncardiac...
Hypertension medication before bedtime reduces diabetes risk Adults with hypertension who do not have diabetes have a lower risk for developing the disease when taking their blood pressure medication at bedtime compared with adults...
Sexual activity does not increase MI risk Sexual activity does not appear to be associated with increased risk for subsequent MI, and patients can safely resume sexual activity after MI, according to a new report in the Journal...
Six studies evaluating influence of environmental factors on CV health From regular exposure to pesticides or air pollution to cataclysmic events such as earthquakes or wildfires, environmental conditions can have a powerful influence on CV health in both the short...
FDA approves ticagrelor for long-term use after ACS event AstraZeneca announced that a 60 mg twice-daily dose of its antiplatelet agent ticagrelor has been approved by the FDA for prevention of CV death, MI and stroke in patients more than 1 year after...
Regular intake of alcohol linked to elevated BP in premenopausal women Alcohol consumption is associated with elevated BP in healthy premenopausal women to a similar degree as reported in previous studies with men, according to neThe researchers wrote...
Proton pump inhibitors may increase MI risk Adults in the U.S. exposed to proton pump inhibitors were at increased risk for developing MI in a recent data-mining study. The researchers evaluated data collected from more than 16...
Analysis From the RE-LY Trial: Changes in Renal Function in Patients With AF Patients with atrial fibrillation (AF) receiving oral anticoagulation exhibited a decline in renal function that was greater in those taking warfarin versus dabigatran, and it was...
Opioid use associated with increased prevalence of AF Opioid use was independently associated with increased prevalence of atrial fibrillation in a new analysis from the Reasons for Geographic and Racial Differences in Stroke, or REGARDS,...
more>>
HCS NEWS
The 27th GW-ICC & APHC 2016 IS NOW CALL FOR ABSTRACTS
April 4 2016
SUBMIT AN ABSTRACT The 27th Great Wall International Cardiology Conference & Asia Pacific Heart Congress 2016(GW-ICC & APHC)will be...
Heart Failure 2016 - next deadlines for our record breaking congress
March 28 2016
Promotion of deadlines (Late Breaking Trials & HFA Career Café) to national HF society members After the excellent news of...
TCT 2016- Abstract Submission
March 28 2016
Free Tickets for Cardio Members - Cardio Update Europe 2016
February 18 2016
8 free tickets to the 2nd Cardio Update Europe 2016 on 1-2 July 2016 in Budapest, representing a total value of 3000 €! (3 regular...
NEW ESC Grants for ESC Congress, education and research
January 29 2016
NEW ESC Grants for ESC Congress, education and research - and more time to apply
EDUCATIONAL SEMINARS FOR RESIDENTS 2015-2016
October 5 2015
1st Educational Seminar for Residents- 25-26 September 2015 Click here to view the programme. 2nd Educational Seminar for Residents- 18-19 December...
Free Registration to EUROCVP 2015 Congress in Rome
April 28 2015
The WG on Pharmacology and Drug Therapy is happy to give to the Young Association of EACVI 50 free registrations to the Course All About Clinical...
36th International Congress of Cardiology- Abstract Submission
March 30 2015
We would like to inform you that the 36th International Cardiology Congress is due to take place on October 29-31 2015, in Thessaloniki, Greece...
ESC CONGRESS 2015
March 23 2015
29 Aug 2015 - 02 Sep 2015 , London - United Kingdom Please browse through the...
World Heart Federation Members Webinar: CVD and the Development Agenda: Advocacy Toolkit- Wednesday 18 March, 16:00 Central European Time
March 17 2015
New Webinar frome the Word Heart Federation. Click here for more details.
ESC Congress News 2014
September 11 2014
Please find below the most important ESC Congress News 2014 SATURDAY 30 AUGUST SUNDAY 31 AUGUST MONDAY 1 SEPTEMBER TUESDAY 2 SEPTEMBER WEDNESDAY...
INAUGUAL SESSION ESC Congress 2014
August 19 2014
INAUGUAL SESSION ESC Congress 2014 Saturday 30 August Barcelona - Central Village 16:30-18:00 We invite all delegates to join this...
Catalogue with the most influential Greek scientists‏
August 7 2014
The list with the most influential Greek scientists is part of a study conducted by Prof. John Ioannidis (University of Ioannina &...
RAFFTING PUBLICATION IN THE INTERNATIONAL JOURNAL OF CARDIOLOGY
August 1 2014
Results from the official Registry of the Hellenic Society of Cardiology RAFTING (Registry of Atrial Fibrillation To Investigate New Guidelines)...
35th INTERNATIONAL CARDIOLOGICAL CONGRESS- ABSTRACT SUBMISSION
May 26 2014
We would like to inform you that the deadline for abstract submission is extended until 30/5/2014.
HEART FAILURE 2014- Athens 17-20 May, OPENING CEREMONY
May 13 2014
35th INTERNATIONAL CARDIOLOGICAL CONGRESS- ABSTRACT SUBMISSION
May 7 2014
We would like to inform you that the deadline for abstract submission is extended until 18/5/2014.
HEART FAILURE 2014- Athens 17-20 May, Free Registration for Greek Residents
April 24 2014
Cardiology Update 2015 21st International Postgraduate Course on Cardiovascular Disease
April 8 2014
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
March 25 2014
Volume: 15 / Number: 4 / Publication Date: March 2014 / Owner: European Society of Cardiology
more >>
cardiomap

 
als-video
Επίδειξη Σεμιναρίου ALS (Advanced Life Support- Εξειδικευμένη Υποστήριξη Ζωής) σε σεμινάριο στην Ελληνική Καρδιολογική Εταιρεία, σε συνεργασία με το ERC (European Resuscitation Council)
Πρόεδρος ΕΚΕ Ι. Καλλικάζαρος
Υπεύθυνος ALS Γ. Λάτσιος
 
 
6 Potamianou 11528 Athens
Phone: +30 210 722 1633, 210 725 8003-8
Fax: +30 210 722 6139
 
facebook    twitter
 
    Sponsors
Powered: By Inspirit Graphics Studio